NDA Group

Welcome to NDA Group

The world’s leading drug development consultancy

We support life science companies all over the world with the single aim to streamline the global development and commercialization process in order to accelerate patient access to important medical therapies.

NDA comprises over 150 dedicated consultants with industry and regulatory agency backgrounds, supported by a network of over 1000 scientific, clinical, regulatory and drug development experts. Our advice covers all phases of development and all major therapeutic areas.

On March 1st 2016 NDA merged with PharmApprove – the scientific communications firm in the US, world leaders in preparing and managing successful FDA Advisory Committee Meetings.

NDA supported over 40% of the new medicinal products that were approved in the EU during 2013-2017. In addition PharmApprove’s success rate for FDA Advisory Committee Meetings tops 80% in the same time period.

With our support you can cut the time and cost it takes to get your product to the patients that need them.